Daniel Harmon
Neurological Surgery · Birmingham, ALNPI 1962610709
Payments from drug & device makers
What this record shows
14 manufacturers reported payments, led by Stryker at 50.1% of the total. Reporting peaked in 2022 at $1,854 and has fallen 86.1% since, to $257 in 2025.
Across 36 payments — averaging $110.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$2K
- Arthrex$630
- Globus Medical$312
- Cerapedics Inc.$248
- Spine Wave, Inc.$204
- Kuros Biosciences USA, Inc$186
- plus $414 from 8 others
What the payments were for
- Travel & lodging$2,22756%
- Food & beverage$1,76844%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 14 | $2,002 |
| Arthrex | 2 | $630 |
| Globus Medical(2 entities) | 3 | $312 |
| Cerapedics Inc. | 4 | $248 |
| Spine Wave, Inc. | 2 | $204 |
| Kuros Biosciences USA, Inc | 1 | $186 |
| Spineology Inc. | 1 | $126 |
| Baxter Healthcare | 1 | $90 |
| Edwards Lifesciences | 2 | $54 |
| Relievant Medsystems, Inc. | 1 | $52 |
| Boston Scientific | 2 | $50 |
| Ulrich Medical USA, Inc. | 1 | $20 |
| Boehringer Ingelheim | 1 | $18 |
| Brainlab, Inc. | 1 | $4 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,995 in reported general payments places this provider in the 60th percentile of 97 neurological surgery providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 75 | $711 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 15 | $157 |
| Oxycodone Hcl | 33 | $137 |
Paid to pharmacies, not to this prescriber.
Other neurological surgery in Birmingham
- Mark HadleyBirmingham$104K
- Andrew ErwoodBirmingham$85K
- Marshall HollandBirmingham$81K
- Jakub GodzikBirmingham$56K
- Adnan ShahidBirmingham$50K
- Jasmine ThumBirmingham$39K
- Jessica BentleyBirmingham$27K
- John FiveashBirmingham$12K
- Joshua MenendezBirmingham$11K
- Zenko HrynkiwBirmingham$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.